- Report
- May 2025
- 100 Pages
Global
From €5196EUR$5,950USD£4,514GBP
- Report
- August 2025
- 194 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP
- Report
- September 2025
- 250 Pages
Global
From €3921EUR$4,490USD£3,406GBP
- Report
- September 2025
- 475 Pages
Global
From €5109EUR$5,850USD£4,438GBP
- Report
- January 2025
- 180 Pages
Global
From €3930EUR$4,500USD£3,414GBP
- Report
- August 2025
- 193 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP
- Report
- September 2025
- 250 Pages
Global
From €3921EUR$4,490USD£3,406GBP
- Report
- September 2025
- 250 Pages
Global
From €3921EUR$4,490USD£3,406GBP
- Report
- July 2025
- 175 Pages
Global
From €3921EUR$4,490USD£3,406GBP
- Report
- September 2025
- 150 Pages
Global
From €3362EUR$3,850USD£2,921GBP
- Report
- September 2025
- 474 Pages
Global
From €5109EUR$5,850USD£4,438GBP
- Report
- July 2023
- 110 Pages
Global
From €3930EUR$4,500USD£3,414GBP
- Report
- July 2024
- 120 Pages
Global
From €4148EUR$4,750USD£3,604GBP
- Report
- April 2023
- 80 Pages
South Korea
From €655EUR$750USD£569GBP
€1310EUR$1,500USD£1,138GBP
- Report
- April 2023
- 80 Pages
United States
From €655EUR$750USD£569GBP
€1310EUR$1,500USD£1,138GBP
- Report
- April 2023
- 80 Pages
United Kingdom
From €655EUR$750USD£569GBP
€1310EUR$1,500USD£1,138GBP
From €655EUR$750USD£569GBP
€1310EUR$1,500USD£1,138GBP
- Report
- April 2023
- 80 Pages
Saudi Arabia
From €655EUR$750USD£569GBP
€1310EUR$1,500USD£1,138GBP
- Report
- April 2023
- 80 Pages
Russia
From €655EUR$750USD£569GBP
€1310EUR$1,500USD£1,138GBP
- Report
- April 2023
- 80 Pages
Poland
From €655EUR$750USD£569GBP
€1310EUR$1,500USD£1,138GBP

The Respiratory Disease Vaccine market is a subset of the larger Respiratory Drugs market. Vaccines are used to prevent the spread of respiratory diseases, such as influenza, pneumonia, and tuberculosis. Vaccines are typically administered to children and adults, and are often recommended for those at high risk of developing respiratory diseases. Vaccines are typically administered through injection, nasal spray, or oral drops.
The Respiratory Disease Vaccine market is highly competitive, with many companies offering a variety of vaccines. Companies in the market include Merck, GlaxoSmithKline, Sanofi Pasteur, Pfizer, and Novartis. These companies are involved in the research, development, and production of vaccines for a variety of respiratory diseases. Additionally, many of these companies are involved in the distribution of vaccines to healthcare providers and pharmacies. Show Less Read more